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The objective of this study was to evaluate Bacillus megaterium, Bacillus 
licheniformis, and Bacillus subtilis, as probiotic strains compared to Bacitracin 
Methylene Disalicylate (BMD) 50 as the antibiotic growth promotor, 
supplemented in commercial broiler rations and their influences on performance, 
yield, and intestinal microbiota. This trial was completed as a randomized-block 
design with 4,800 birds split into 96, 5’x10’ pens, and randomly assigned to one 
of eight treatment groups. The birds were placed at a stocking density of 1.00 
ft2/bird, (50 birds/pen), and reared on used pine shaving for 55 days. Throughout 
the study, bird performance, and intestine samples were measured. A yield study 
was completed at the end of the study to determine meat yield for all retail cuts. 
Results show treatment 3, (LS + AGP), which consisted of the following 
probiotics and antibiotic growth promotors: Bacillus licheniformus, Bacillus 
subtilis, and BMD with Maxiban in the starter and grower diets as the 
coccidiostat, performed better overall compared to the negative and positive 
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 The poultry industry is one of the leading sectors of the animal industry 
with an increase in demand of poultry products around the world. Global 
production is forecasted to increase one percent to a record 90.4 million tons of 
poultry products by 2017 (USDA, 2016). Therefore, poultry integrators must meet 
demands placed on the industry by increasing both performance and yield. Since 
the beginning of commercialized broiler production, the final goal for the 
producers has been to keep cost as low as possible. One of the largest issues 
broiler producers face is the health of the birds. Diseases are an important 
concern to poultry producers because of lost productivity, increased mortality, 
and the health related issues with consumers eating the meat. Medicating poultry 
has been performed by the industry for many years with the treatment of 
antibiotics (Saif, 2003). Consumers are driving the market toward replacing 
antibiotics. Probiotics could be the next choice for integrators. Unlike antibiotics, 
probiotics are living organisms and rely on survival and replication in the gastro-
intestinal tract (Patterson & Burkholder, 2003). Probiotics are aimed at promoting 
the growth of beneficial gut microbes. Some more recently introduced probiotics 
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are competitive exclusion products which help to eliminate other microbes. 
During this study we evaluated different probiotic strains used as supplements in 
commercial broiler rations and evaluated their influences on performance, yield, 
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Statement of Problem 
 Antibiotic free chicken is currently trending within the United States of 
America. The European Union has banned the use of human antibiotics as 
growth promotors in animal feed since 2006 (Wang et al., 2016). The main 
expected consequence of the ban is a reduction in the amount of antibiotics used 
in animal production, and therefore the risk of transferring resistant genes from 
microbes to the human population (Castanon, 2007). With such urgency of 
banning antibiotics in the U.S., probiotics and prebiotics may become the next 
viable option for substitution. Bacillus is an established bacteria within the 
intestinal tract of the bird, therefore using this bacteria as a probiotic could 
possibly help support the overall health.  
Research Objectives 
The objective for this study was to supplement three different probiotic 
strains of bacteria, at various combinations, within commercial broiler chicken 
diets and evaluate the effects on bird performance, meat yield and intestinal 
microbial ecology. Performance evaluation was achieved by comparing average 
body weights per pen across all treatments. Data was collected to calculate feed 
conversion ratio (FCR), and adjusted feed conversion ratio. Intestinal samples 
were collected on day 25, d35, & d55 and analyzed for 16 rRNA genomic 
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CHAPTER II  
Literature Review 
Probiotics in Poultry 
The key to successfully rearing poultry to the desired body weight for 
market without antibiotic growth promoters (AGP) is to control and maintain a 
healthy and diverse gut microflora (Barug et al., 2006). Specific carbohydrates, 
prebiotics, probiotics, and beneficial microorganisms have been identified to 
eliminate potential pathogens and alter intestinal microflora (Barug et al., 2006). 
Essentially, prebiotics and probiotics both have the same mode of action: to 
increase resistance of infection and reduce the risk of increasing potential 
pathogens. Combinations of prebiotics and probiotics are known as synbiotics 
(Patterson & Burkholder, 2003). According to the currently adopted definition by 
Food and Agricultural Organization/ World Health Organization (FAO/WHO, 
2001) probiotics are “living microorganisms which when administered in 
adequate amounts confer a health benefit on the host”. Probiotic bacteria have 
the ability to bind to intestinal mucus, and it has been suggested that adhesion 
may be a key for applying their protective effect (Bernet et al., 1994). 
Increased resistance to antibiotics in humans has attracted attention in 
governmental and public interest to eliminate the usage of antibiotics in 
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animals. Recent changes in legislation have driven the need for different variety 
of feed requirements on the use of antimicrobials. The gastrointestinal (GI) tract 
is densely populated with microorganisms which interact closely and intensely 
with the host and ingested feed. Sub-therapeutic use of probiotic 
microorganisms, prebiotic substrates that enrich certain bacterial populations, or 
a combination of the two have been an alternative method to antibiotics in 
livestock (Patterson & Burkholder, 2003). Sub-therapeutic is defined as, a drug at 
a lower dosage than required for a therapeutic effect. Probiotic, which means “for 
life” in Greek (Gibson & Fuller 2000), has been defined as “a live microbial feed 
supplement which beneficially affects the host animal by improving its intestinal 
balance” (Fuller, 1989). Pathogens need to overcome many obstacles to colonize 
and create an infection in the gut. Probiotics help fight infections with beneficial 
bacteria, unlike antibiotics where a bactericidal drug kills the bacteria; however a 
bacteriostatic drug inhibits the replication of the bacteria and requires a functional 
immune system to eliminate the bacteria from the body (Saif, 2003). Competitive 
exclusion (CE) is a term that has been used to describe the protective effect of 
the natural or native bacterial flora of the intestine in limiting the colonization of 
some bacterial pathogens (Jeffrey, 1999). CE may provide products for the 
poultry industry in combating the occurrence of intestinal disease and reduction 
of pathogens (Jeffery, 1999). Carbohydrates are at the center of cell to cell 
functions. Specific surface carbohydrates permit viruses and bacteria to attach to 
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the cell surface, to colonize, and in the case of a pathogen, cause disease 
(Barug et al., 2006). Different carbohydrate structures can have different 
biological activities. Monosaccharides, sugars, are known for directing the 
movement of cells and proteins throughout the body, organizing embryonic 
development, regulating hormones, and regulating the immune system (Benz & 
Schmidt, 2001). 
 Probiotics can be administered to the chicken through the diet, water, or 
by liquid spray. Probiotics currently are viewed as production enhancers to affect 
microflora positively to promote performance and protect against colonization of 
harmful bacteria (Hume, 2011). The concept of probiotics is not entirely new, the 
distribution of how, when, and where to use them is the key factor. The most 
common additives include Bacillus, lactic acid bacteria and yeast, out of which 
Aspergillus, Bacillus, Bifidiobacterium, Candida, Lactobacillus and Sterptomyces 
are widely used in the broiler industries (Islam et. al., 2004; Gil et al., 2005; Willis 
et al., 2007; Apata, 2008). The ultimate goal of commercial application of 
probiotics is to increase economic profitability modulated by 3 hopeful results: 1) 
a demonstrable increase in animal performance; 2) reduction in morbidity and 
mortality in the animals; and 3) reduction in human pathogenic bacterial 
populations (Flint & Garner 2009). These goals are not mutually exclusive and 
beneficial outcomes are, in fact, tightly interwoven with one another.  
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Bacillus Bacteria 
Bacillus licheniformis, Bacillus subtilis, and Bacillus megaterium were the 
probiotics used in this trial. Bacillus is a genus of bacteria that are gram-positive, 
rod-shaped and found widespread in the environment. They are usually called 
“soil bacteria”, even though they can be found in soil, water, dust, air and feces 
(Bacillus Bacteria, 2012). Bacterial spores are particularly well suited for use as 
live microbial products as they are metabolically dormant and highly resilient to 
environmental stresses, indicated by Cartman et al., (2008). These essential 
properties are highly desirable from a commercial perspective and spore-based 
products have a long shelf life and retain their sustainability during distribution 
and storage. Saif (2003) stated that Bacillus spp. occasionally has been 
associated with embryo mortality and yolk sac infections in chickens and turkeys. 
Certain strains of Bacillus interfere with intestinal colonization of enteric 
pathogens and have value as probiotics (Saif, 2003). Knarreborg and colleagues 
(2008) showed that the addition of Bacillus spores in broiler chicken feed 
increased the microbial diversity in the ileum and increased the growth of lactic 
acid bacteria in the birds fed Bacillus organisms compared to the control birds.  
 Bacillus licheniformis produces keratinases (subtilisins) and have the 
ability to degrade feathers. Feather degradation is associated with focal 
ulcerative dermatitis of turkey breast skin but a correlation between keratinase 
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exposure and lesion formation has not been investigated (Saif, 2003). Knap and 
colleagues (2011) have shown that studies with B. licheniformis spores as a 
probiotic has the ability to prevent necrotic enteritis (NE) and could be an 
alternative to prophylactic use of antibiotics to overcome NE under commercial 
conditions. Bacillus licheniformis could therefore be of direct use in preventing 
antibiotic-resistant pathogens in chickens (Knap et al., 2011).  
It has been suggested that Bacillus subtilis will associate with the gut wall 
and favor the balance of beneficial intestinal microflora (Jiraphocakul, et al., 
1990). Research by Tactacan and colleagues (2013) showed that an adequate 
level of dietary B. subtilis spores supplemented was equally as effective as 
Bacitracin Methylene Disalicylate (BMD) in mitigating the subclinical effects of NE 
in broiler chickens. Replacing BMD with B. subtilis would be not only reasonable 
but profitable in the commercial industry.    
In 1884, De Bary named Bacillus megaterium “big beast” because of its 
large size with a volume approximately 100 times that of Escherichia coli (De 
Bary, 1884). B. megaterium is a gram-positive, mainly aerobic spore-forming 
bacterium found in widely diverse habitats from soil to seawater, sediment, rice 
paddies, honey, fish, and dried food (Vary et al., 2007). The poultry industry has 
used feather wastes as an ingredient in animal feed stuffs because feathers are 
almost pure keratin protein. Generally, they become feather meal used as animal 
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feed after undergoing physical and chemical treatments. These processes 
require significant energy and also destroy certain amino acids (Papadoulos et 
al., 1986). Therefore, biodegradation of feather keratin by microorganisms 
represents an alternative method to improve the nutritional value of feather 
remains and to prevent environment pollution. B. megaterium has the capability 
of keratin degradation from research shown by Park and colleagues (2007) and 
degraded whole chicken feathers completely within seven days.    
Gut Health in Poultry 
 Gut health is critical when discussing performance of broilers in the 
commercial industry. A well balanced ration sufficient in energy and nutrients is 
exceptionally important in maintaining a healthy gut. It is not surprising 
considering the gut holds more than 640 known different species of bacteria, 
contains over 20 different hormones, digests and absorbs the vast majority of 
nutrients, and accounts for 20% of energy the body uses (Choct, 2009). The 
balance of the microflora in the gut reflects the performance of the bird itself. 
Nutrient uptake from the diet will affect the probiotic, prebiotic, or antibiotic 
needed to perform ideally. Not only is the gut a major organ for digestion and 
absorption, it is also the first protective mechanism against pathogens which can 
enter host cells and tissues (Choct, 2009).  
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The conflicting side to a healthy gut would be one infected by bacteria 
such as, Clostridium, Salmonella, and Campylobacter. Necrotic enteritis is 
defined as, an acute chronic enterotoxaemia caused by Clostridium perfringens 
and characterized by fibrino-necrotic enteritis, usually of the small intestine 
(McMullin, 2004). This disease occurs sporadically, but mortality can be very high 
in untreated flocks. Infection of NE mainly occurs by fecal to oral transmission 
(McMullin, 2004). Clinical signs are depression, ruffled feathers, immobility, and 
dark colored diarrhea. Illness is caused by the proliferation of C. perfringes (type 
C) often occurs in association with outbreaks of coccidiosis or any other situation 
which causes damage to the lining of the intestine (Pattison, 1993). Coccidiosis 
is extremely difficult to control. A coccidiostat is included in the diet in an attempt 
to control the disease, without totally eliminating the coccidia, described by 
Pattison (1993). The idea is to allow the coccidia to survive and reproduce in the 
gut of the bird in sufficient numbers to stimulate immunity. There are few 
strategies and tools available for control and prevention of C. perfringens. The 
most cost-effective control will most likely be obtained by balancing the 
composition of the diet as stated by Van Immerseel and colleagues (2004).  
The genus Salmonella contains many species of bacteria, all of which may 
cause problems, though some more than others. Two species, S. pullorum and 
S. gallinarum are generally restricted to poultry (Pattison, 1993). Techniques at 
commercial processing facilities can result in carcass or meat contamination of 
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products. If the product is mishandled then low numbers of salmonella organisms 
can multiply quickly up to a level at which they are capable of causing food 
poisoning in humans. Efforts are being made by the USDA Food Safety and 
Inspection Services to reduce Salmonella in the processing facilities (USDA, 
2017). There are a few preventative measures taken to reduce the amount of 
pathogenic bacteria. A few examples are biosecurity measures, competitive 
exclusion, vaccination, host genetic selection, and the use of antimicrobial 
alternatives (Lin, 2009).  
Campylobacter, primarily Campylobacter jejuni and Campylobacter coli, 
are well adapted to the avian host and reside in the intestinal tract of birds (Saif, 
2003). Studies have shown that despite extensive colonization, Campylobacter 
infections produce little or no clinical diseases in poultry. Saif also states that 
although thermophilic campylobacters are not significant pathogens for poultry, 
they are of importance to food safety and public health with C. jejuni being 
responsible for the majority of campylobacteriosis. Campylobacter has now 
emerged as a leading bacterial cause of foodborne gastroenteritis in humans 
around the world (Saif, 2003).  
Intestinal Microbiota 
 Key reasons for maintaining a healthy gut is because the gut is 
responsible for digestion and absorption of nutrients. If the gut is impaired in any 
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way, digestion and absorption of feed will be altered, as well as, performance 
and overall health of the bird. Factors such as injury, stress, and nutrition can 
leave the host more susceptible to disease. Age of the bird is critical for 
developing a resilient immune system. Within the first few hours of a newly 
hatched chick, the normal gut bacteria (microflora) that inhabit the intestine 
become established (Jeffrey, 1999). Functions of the microflora are to breakdown 
ingested food, produce some vitamins and mostly provide a natural barrier of 
protection to harmful bacteria that enter the host cell (Jeffrey, 1999). The overall 
microbiota varies from bird to bird, and broilers can contain many different 
bacteria species in the gastrointestinal community. Environmental settings can 
also affect the performance of the microbial communities based on management 
practices and litter control. According to Apajalahti & Bedford (2000), these 
factors affect birds both directly and indirectly by recycling microbes and 
weakening immunity. Poultry litter is another main source of infection to the birds 
and meat contamination. Litter is consisted of a mixture between poultry wastes 
with bedding materials that cover the floor in commercial poultry houses (Grimes 
et al., 2006). Rice hulls, processed paper pellets, sand, peanut hulls, crushed 
corn cobs, chopped straw and wood shavings are most commonly used due to 
feasibility and convenience of resources in specific regions of the world (Ritz et 
al., 2009). Viability of these bedding materials is due to their absorption and 
storage properties of poultry wastes during the rearing of broilers. Tewolde and 
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colleagues (2005) presented in studies that litter is high in phosphorus and 
nitrogen content, which is being used as a fertilizer for crops. Broiler litter is also 
shown to be a better soil conditioner than synthetic fertilizers by Tewolde and 
colleagues (2005). At the opposite end of the spectrum, Brake (1992) has stated 
that continuous growth in the poultry industry has led to a problem with litter 
disposal, which has resulted in farmers recycling used bedding material inside 
chicken houses. Nevertheless, recycling of litter can lead to increased levels of 
parasitic and bacterial infections of the birds. Poultry litter is considered an 
environmental ecosystem with an extensive range of biotic properties. Barker 
(1996) stated that the physiochemical properties within the litter environment 
favor the establishment of a large microbial and parasitic community that are 
mostly of intestinal origin. According to the USDA, 12.3 million metric tons of 
poultry litter is produced annually for every 8.5 million broilers (Chamblee, 2002), 
causing a high number of bacteria which would be a problem for their disposal.  
Bacteria, such as lactic acid producing bacteria, are at the historical core 
of the discussion when the use of probiotic heath supplements and therapeutics 
are considered (Hume, 2011). Lactic acid bacteria make up a group of bacteria 
that degrade carbohydrates with the production of lactic acid. A few examples of 
bacteria containing lactic acid are Streptococcus, Lactobacillus, Lactococcus, 
and Leuconostoc. These bacteria are gram-positive that do not form spores and 
are able to grow both in the presence and absence of oxygen. Lactic acid 
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bacteria can also manufacture compounds needed to survive and grow in many 
types of environments.  
A number of known microorganisms, mainly the lactic acid producing 
bacterial species enterococci, bifidobacteria, and lactobacilli, as well as a smaller 
number of unidentified microbial cultures are normally used as probiotics (Barug 
et al., 2006). 
Stress Related Bacteria  
 Stresses in poultry production are a harsh reality. The development of the 
poultry industry has been due in part, to the ability of the chicken to 
accommodate many of the stresses imposed on them by modern production 
techniques. Such stressors include genetic selection for increased growth rate 
and egg numbers, environmental and management changes, increased diseases 
challenges and exposure to a wide array of pharmaceuticals and vaccines 
needed to maintain a healthy flock. It is important to understand what bacteria 
are related to stress and how bacteria can affect the health of the bird. When 
conditions are perfect, such as, feed quality and diet, temperature, water pH, and 
ventilation, there is a low amount of stress on the chicken. As conditions vary, the 
intestinal microbiota will fluctuate. Lactobacilli and Bifidobacterial species seem 
to be stress sensitive, and these populations tend to decrease when a bird is 
under stress (Patterson & Burkholder 2003). Lactobacillus is a bacteria producing 
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lactic acid from the fermentation of carbohydrates. Bifidobacteria is a gram-
positive anaerobic bacterium, usually found in the GI-tract of the bird (Patterson 
& Burkholder 2003). The reason these microbes are so unusual in the beneficial 
bacteria world, is that the bacteria form endospores under stressful conditions 
(Bacillus Bacteria, 2012). The endospores have a tough coating in order to 
protect the dormant bacteria within. This coating is able to last for years and can 
resist extreme heat, radiation, extreme freezing, drying, and chemical 
disinfectants (Bacillus Bacteria, 2012).  
Antibiotics as Growth Promotors  
 Studies by Castanon (2007) stated the growth promoter effect of 
antibiotics was discovered in the 1940s, when it was observed that animals fed 
dried mycelia of Streptomyces aureofaciens containing chlortetracycline residues 
improved their growth. The United States Food and Drug Administration 
approved the use of antibiotics as animal feed additives without veterinary 
prescription in 1951 (Jones & Ricke, 2003). Antibiotics are the chemical products 
obtained from certain strains of micro-organisms at low concentrations that can 
inhibit the growth of other micro-organisms, and may even cause their death. In 
the past, the use of antibiotics in food, as treatment and either at a lower level of 
care (as growth promoters) was widespread (Visek, 1978 & Shane, 2005), but 
the use of antibiotics in livestock and poultry may increase bacterial resistance. 
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Concerns from consumers have shifted the market of the broiler industry by 
substituting antibiotics with probiotics, prebiotics or other alternatives.  
Consumers are worried the antibiotic given to the animal could be transferred to 
the human upon digestion of the meat. The European Union has banned the use 
of human antibiotics as growth promotors in animal feed since 2006 (Wang et al., 
2016). The main expected consequence of the ban is a reduction of the amount 
of antibiotics used in animal production, and therefore the risk of transferring to 
persons of microbial with resistant genes to antibiotics (Castanon, 2007). 
In this research, the antibiotic growth promotor of choice was Bacitracin 
Methylene Disalicylate (BMD). BMD is used for the prevention and control of 
necrotic enteritis, increased rate of weight gain and improved feed efficiency. It 
preserves the integrity of the gut wall, helping absorb the nutrients needed from 
the feed within the diet (Miller et al., 2017). This antibiotic also reduces 
subclinical and clinical disease, resulting in greater productivity and decreased 
mortality. Much of the work with antibiotic growth promoters continues to be from 
the standpoint of studying the effects on easily cultured bacterial populations 
such as Lactobacilli and Clostridium perfringes and poultry health rather than 
resulting physical changes to the gastrointestinal tract (Engberg et al., 2000). 
Pyrosequencing of DNA  
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A variety of methods are available for sequencing DNA, but Sanger and 
pyrosequencing are two of the most commonly used today. The Sanger method 
is also known as terminator sequencing because DNA fragments of varying 
lengths are synthesized by incorporating both nucleotides and 
dideoxyterminators (deoxyribonucleotide triphosphates [dNTPs] and 
dideoxynucleotide triphosphates [ddNTPs], respectively) (Harrington, 2013).  
Pyrosequencing is designated as a sequence-by-synthesis technique 
because DNA synthesis is monitored in real time. It is based on the pioneering 
and sophisticated, basic science work of Pal Nyren, PhD, who first demonstrated 
in 1987 that DNA polymerization can be monitored by measuring pyrophosphate 
production, which can be detected by light (Nyren, 1987). Small change in 
bacterial population could be easily analyzed with the advancement in high-
throughput techniques like pyrosequencing. Pyrosequencing is one of the next 
generation sequencing methods that has revolutionized the field of biology. It 
provides an ample amount of volume of information from a small amount of 
sample collected. Pyrosequencing employs sequencing by enzymatic approach 
and is based on detecting the activity of DNA polymerase with another 
chemiluminescent enzyme (Manoharan, 2013). The pyrophosphates (ppi) 
released during DNA syntheses (as the dNTPs are added to the new strand by 
DNA polymerase) are proportionally converted in to a chemiluminescent signal 
by a cascade of enzymatic reactions and quantified (Ronaghi, 1998; Ronaghi, 
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2001). At present, the widely used method for pyrosequencing is the bacterial 
16S rRNA Tag-Encoded FLX Amplicon Pyrosequencing (bTEFAP) approach.  
Studies by Van Kley, (2013) has shown that overall, pyrosequencing has 
helped to further understand the diversity of cecal microbial communities, 
demonstrate a method to determine the dynamics of microbial communities and 
also establish the functionality of the microbial community with broiler 
performance. 
Research conducted by Nonnenmann and colleagues (2010) studying the 
bacteria and fungi present in organic dust from commercial poultry houses have 
been largely limited to culture-based techniques (Clark, 1983 & Lee, 2006). The 
low cost and the fast processing speed of this pyrosequencing technology may 
revolutionize the ability to identify the distribution and concentration of 
bioaerosols, stated by Nonnenmann and colleagues (2010).  
Another method, so the data obtained is more reliable, has been 
developed by one of the Roche companies, 454 life sciences, is a high-
throughput DNA sequencing method which employs massive parallel 
sequencing-by-synthesis approach (Manoharan, 2013). With this method, we 
could sequence any double-stranded DNA which enables a variety of 
applications including de novo whole genome sequencing, re-sequencing of 
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whole genomes and target DNA regions and metagenomics (454 Life Sciences, 
2011).  
Veterinary Feed Directive 2017 
 The Food and Drug Administration (FDA) has adjusted the animal drug 
regulations to implement the veterinary feed directive (VFD) drugs section of the 
Animal Drug Availability Act of 1996 (ADAA) (FDA, 2017). This amendment is 
intended to improve the efficiency of FDA’s VFD program while protecting human 
and animal health.  
 VFD drugs are a list of animal drugs intended for use in or on animal feed 
which are limited to use under the professional supervision of a licensed 
veterinarian. Any animal feed containing a VFD drug can only be fed to animals 
based upon an order, called a veterinary feed directive (VFD), issued by a 
licensed veterinarian in the course of the veterinarian's professional practice 
(FDA, 2017).  
Disease Prevention  
Understanding interactions between animals and humans is critical in 
preventing outbreaks of zoonotic disease. Biosecurity practices are designed to 
prevent the spread of disease. Rodent control, vaccination programs, disposal of 
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mortality and sanitation practices are other critical actions important to disease 
prevention, although it cannot provide total protection against infection.  
Many management factors have an influence on disease control and 
prevention. People are considered to be one of the largest vectors as to carrying 
poultry diseases onto poultry farms, particularly on their footwear, clothing and 
hands. Contaminated vehicles, equipment, flies and wild birds are also factors 
that could potentially carry diseases into a poultry farm. Bahrndorff and 
colleagues (2013) stated in his research that by using fly screens to prevent flies 
from entering broiler chicken houses, it was possible to reduce the prevalence of 
Campylobacter spp. positive flocks from 41.4% to 10.3%.  
The clean-out period between flocks in the poultry houses is critical to the 
health of the forthcoming flock. Young chicks are more disease-sensitive than 
older birds. Poultry housing and environmental factors can influence the 
occurrence of disease. Poor chicken litter conditions may include wet or poor 
bedding quality, inadequate litter depth, poor site drainage, house condensation 
problems, improper management of the drinkers, cooling and ventilation 
systems, and not maintaining uniform bird density in the houses (Malone, 2004). 
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CHAPTER III 
Materials and Methods 
Animals and Housing 
 This study began on March 11, 2016 and was completed on May 5, 2016. 
This study was conducted using one day old, co-mingled, mixture of male and 
female, Cobb chickens supplied by Pilgrim’s Pride in Nacogdoches, Texas. A 
total of 4,800 birds, 600 birds per treatment group, were placed within 96, 5’X10’ 
floor pens in a randomized-block design at the SFASU Poultry Research Center. 
Birds were randomly divided within the pens at a stocking density of 1.00 ft²/bird 
(50 birds/pen). Birds were reared on used pine shavings for 55 days. Food and 
water were administered ad libitum basis throughout the study to the birds. Water 
was provided via Lubing FeatherSoft® nipple drinkers, while feed was provided 
via two, 30lb. hanging tube feeders. All 4,800 broilers were reared in the same 
house under standard commercial industry practices. This house is split into two 
equal halves with each half containing 48 individual pens. These pens were then 
separated into twelve different blocks with each block containing one pen for 
each of the eight treatment groups. The experiment was arranged specifically to 
minimize environmental variation created by the bird’s location within the house. 
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The LED light bulbs of choice in this research were Overdrive A19 bulbs. 
The lighting program used followed an industry standard lighting program. The 
birds received 24 hours of light at 100% intensity for the first 6 days. On day 7, 
the intensity level was reduced to 80%. By day 8, the intensity level was reduced 
to 60%. Day 9, the intensity level was reduced to 40%. Days 10-14, the intensity 
level was reduced to 20% and remained at this intensity for the remainder of the 
study. Total hours of light were reduced from 24 hours to 16 hours for days 7-14. 
Reducing hours of light during the growing period allows the birds to develop 
their skeletal system prior to putting on large amounts of muscle. At day 15-48, 
the total amount of hours was increased to 18. From day 49 to the end of the 
study, total hours of light were increased again to reach 20 hours. The reasoning 
for reduction of lighting intensity as the birds grow is because of behavioral 
developments. The birds will tend to fight to show dominance and cause scratch 
marks on the skin. Once the lights have been reduced to a dimmer intensity, the 
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Table 1. Lighting Treatment 
Lighting Treatment   







Cycle 1 Cycle 2 
0 to 6 100% 0 24 00:00-00:00 
 
7 80% 30 16 06:00-22:00 
 
8 60% 30 16 06:00-22:00 
 
9 40% 30 16 06:00-22:00 
 
10 to 14 20% 30 16 06:00-22:00 
 
15 to 48 20% 30 18 06:00-24:00 
 
49 to END 20% 30 20 06:00-02:00 
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Experimental Treatment and Groups 
 This study had a total of 8 different treatment groups (600 birds with 12 
replications/TX). The individual treatments associated with probiotics, antibiotic 
growth promotor, coccidiostat and vaccines are listed in Table 2. Probiotics were 
supplemented at 2.0 x 106 CFU/gram of feed. CFU stands for Colony Forming 
Units.  
Treatment 1 was the negative control (NC). Negative control is a treatment 
without any products or additives mixed within the diet with the exception of 
Maxiban in the starter and grower diets as the coccidiostat. Treatment 2 was the 
positive control (PC), which is the standard diet with an antibiotic growth 
promotor, BMD. BMD was added in the starter and grower diets at 50 grams per 
ton, and Maxiban was also added in the starter and grower diets as the 
coccidiostat. Treatment 3, (LS + AGP), had the following probiotics and antibiotic 
growth promotors: Bacillus licheniformus, Bacillus subtilis, and BMD with 
Maxiban in the starter and grower diets as the coccidiostat. Treatment 4, (LMS + 
AGP), had the following probiotics and antibiotic growth promotors: Bacillus 
licheniformus, Bacillus megaterium, Bacillus subtilis, and BMD with Maxiban in 
the starter and grower diets as the coccidiostat. Treatment 5, (LS + NO AGP), 
had the following probiotics and no antibiotic growth promotors: Bacillus 
licheniformus and Bacillus subtilis, with Maxiban in the starter and grower diets 
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as the coccidiostat. Treatment 6, (LMS + NO AGP), had the following probiotics 
and no antibiotic growth promotors: Bacillus licheniformus, Bacillus megaterium, 
and Bacillus subtilis, with Maxiban in the starter and grower diets as the 
coccidiostat. Bioshuttle is the application of a vaccine on day of hatch, and then 
followed up by a coccidiostat within the grower to help clean up after the vaccine. 
Treatment 7, (LS + Bioshuttle), had the following probiotics and antibiotic growth 
promotors: Bacillus licheniformus, Bacillus subtilis, with BMD in the starter and 
grower along with Salinomycin as the coccidiostat at a rate of 45 grams per ton in 
the grower diet only. Advent coccidiosis vaccine was also administered to 
treatment 7 (LS + Bioshuttle), at day of hatch. Treatment 8 (LMS + Bioshuttle) 
had the following probiotics and antibiotic growth promotors: Bacillus 
licheniformus, Bacillus megaterium, Bacillus subtilis, with BMD in the starter and 
grower along with Salinomycin in the grower diets only as the coccidiostat. 
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day of hatch 
*Probiotics were supplemented at 2.0 x 106 CFU/gram of feed.  
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Feed 
 All basal diets were supplied by Pilgrim’s Pride. The basal diets were 
formulated to be complete for all nutrients required by the birds. Feeding phases 
consisted of a starter (S), grower (G), withdrawal (W) diets with feed changes 
occurring at approximately at day 15, day 33, and day 55, respectively.  Diets 
were back formulated to meet the negative control treatments needs prior to 
arrival to the SFASU Research Feed Mill. Diets were formulated according to the 
treatments, mixed, pelletized, weighed and recorded. Feed samples were 
retained for analysis. The feed was provided ad libitum throughout the study via 
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Performance Data 
 All birds in each pen were counted and weighed collectively on days (d) 1, 
d15, d33, and d55. These days represented approximate times for feed change, 
d15 was the end of the starter phase, d33 was the end of the grower phase, and 
d55 was the end of the withdrawal phase. All feed was weighed and recorded 
prior to delivery to each pen. The chickens were delivered by Pilgrim’s Pride on 
their delivery truck in chick trays. On day one, the farm crew, along with help 
from Dr. Joey Bray, counted and weighed 50 chicks on a Doron 8000XL table top 
scale before placement into their pen. While in the procedure of weighing the 
chicks, any deformities, open navels, or cull birds were euthanized properly via 
cervical dislocation. Weights were analyzed to determine average body weight 
per treatment group. In order to collect the data, each bird was placed in an 
aluminum cage with five separate levels, with load cells on the bottom to capture 
the collective weight. All feed remaining in each pen on assigned weigh days 
were placed on the scale, weighed, and recorded. Data was used to calculate 
feed conversion ratio, and adjusted feed conversion ratio for each treatment. 
Mortality was checked daily. All mortality was collected, weighed, necropsied, 
and recorded. Probable cause of death was noted.  
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Intestinal Sampling for 16S rRNA Sequencing 
 Intestinal samples were collected from 8 randomly selected birds per 
treatment group on d25, d35, and d55 then analyzed for total microbiome by 
Omega Bio-Tek, Inc. in Norcross, GA. 
 16S rRNA sequencing is designated as a sequence-by-synthesis 
technique because DNA synthesis is monitored in real time. It employs 
sequencing by enzymatic approach and is based on detecting the activity of DNA 
polymerase with another chemiluminescent enzyme. Pyrosequencing also 
provides an ample amount of volume of information from a small amount of 
sample collected. Because of its fast processing speed, pyrosequencing 
technology may revolutionize the ability to identify the distribution and 
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Yield Study 
 At the completion of the study, four randomly-selected birds/pen (two 
males & two females identified by sexual characteristics), for a total of 384 birds 
were individually weighed, recorded, and wing tagged. A numbered wing tag was 
placed in the wing web of each bird for further individual identification throughout 
the yield process. Birds from each treatment group remained together and were 
placed in individual isolation pens until the time of processing. Birds were 
provided feed and water until 10 hours prior to processing, when the feed only 
was removed until transit time.  
 The processing stage begins at the euthanasia station where the birds are 
electrically stunned before severing the carotid artery and jugular vein in the 
neck. Once the birds have been exsanguinated, they were transferred to the 
scalder. The scalder is filled with water and the temperature is set to 140°F while 
turning for 90 seconds. Inside the scalder is a rotating plate which tumbles the 
chickens causing the feather follicles to open and feathers to loosen from the 
skin. The next step in the processing phase is to transport them into the plucker. 
The plucker has rubber finger-like studs along the bottom and wall of the 
machine, when added with water, the inside of the machine rotates clockwise for 
90 seconds plucking the feathers from the skin of the bird. Once completed, the 
hocks are removed from the lower portion of the bird and discarded 
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appropriately. The birds are hanged upside down on a rotating shackle line for 
removal of the neck and tail. After the neck and tail have been removed, the birds 
are then eviscerated, removing all organs and intestines. At this point, the front-
half and hind-half are separated. The front-half remains whole until later. The 
hind-half is then cut into sections, such as drums, thighs, back and fat pad. All 
parts of the carcass are then placed within a colander where the hind-half parts 
are recorded through a scale connected to a computer. Once the hind-half has 
been removed and placed into the chiller, the front-half is cut up into breast, 
tenders, wings, frame and skin. The skin weights recorded were only from the 
breast of the carcass. The same procedure of weighing the front-half of the 
carcass was repeated like the hind-half.   
Birds were processed for yield analysis and the following weights were 
recorded: without giblets (WOG), front-half carcass, hind-half carcass, breasts, 
tenders, wings, drums, thighs, frame, back, abdominal fat pad, and skin. All 
remaining birds were processed by Pilgrim’s Pride for commercial distribution. 
The yield analysis helped determine if the probiotics had any effect on intestinal 
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Data Interpretations 
 The data was collected at the Stephen F. Austin State University Poultry 
Research Center and was statistically analyzed using Statistical Analysis System 
(SAS 9.2) (Cary, NC). The data was interpreted using a one-way, analysis of 
variance (ANOVA) using the PROC GLM procedure. When significance between 
the treatments was observed, at the alpha level of P < 0.05, means were 
separated using the least squares means test with the PDIFF option of this 
procedure. Means were separated using Duncan’s Multiple Range Test. 
Duncan’s Multiple Range Test allowed the results to be analyzed by testing all 
treatment groups against themselves. Duncan’s Multiple Range Test was only 
performed to determine the differences between performance and yield data. 
Dunnet’s Multiple Range Test allowed the results to be tested individually against 
the control group. Dunnet’s test was only used to determine the difference in 
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CHAPTER IV 
Results and Discussion 
At the completion of the study, all of the performance parameters and 
yield data were collected and evaluated by the researcher and poultry thesis 
research director. The following is a compilation of the results determined from 
this research trial. Treatment 1 was the negative control (NC). Negative control is 
a treatment without any products or additives mixed within the diet with the 
exception of Maxiban in the starter and grower diets as the coccidiostat. 
Treatment 2 was the positive control (PC), which is the standard diet with an 
antibiotic growth promotor, BMD. BMD was added in the starter and grower diets 
at 50 grams per ton, and Maxiban was also added in the starter and grower diets 
as the coccidiostat. Treatment 3, (LS + AGP), had the following probiotics and 
antibiotic growth promotors: Bacillus licheniformus, Bacillus subtilis, and BMD 
with Maxiban in the starter and grower diets as the coccidiostat. Treatment 4, 
(LMS + AGP), had the following probiotics and antibiotic growth promotors: 
Bacillus licheniformus, Bacillus megaterium, Bacillus subtilis, and BMD with 
Maxiban in the starter and grower diets as the coccidiostat. Treatment 5, (LS + 
NO AGP), had the following probiotics and no antibiotic growth promotors: 
Bacillus licheniformus and Bacillus subtilis, with Maxiban in the starter and 
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grower diets as the coccidiostat. Treatment 6, (LMS + NO AGP), had the 
following probiotics and no antibiotic growth promotors: Bacillus licheniformus, 
Bacillus megaterium, and Bacillus subtilis, with Maxiban in the starter and grower 
diets as the coccidiostat. Bioshuttle is the application of a vaccine on day of 
hatch, and then followed up by a coccidiostat within the diet to help stimulate the 
vaccine. Treatment 7, (LS + Bioshuttle), had the following probiotics and 
antibiotic growth promotors: Bacillus licheniformus, Bacillus subtilis, with BMD in 
the starter and grower along with Salinomycin as the coccidiostat at a rate of 45 
grams per ton in the grower diet only. Advent coccidiosis vaccine was also 
administered to treatment 7 (LS + Bioshuttle), at day of hatch. Treatment 8 (LMS 
+ Bioshuttle) had the following probiotics and antibiotic growth promotors: 
Bacillus licheniformus, Bacillus megaterium, Bacillus subtilis, with BMD in the 
starter and grower along with Salinomycin in the grower diets only as the 
coccidiostat. Advent coccidiosis vaccine was also administered to treatment 8 at 
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Growth Performance 
Average body weights and feed conversion ratios were measured on 
multiple occasions throughout the study. Feed conversion ratio is a measurement 
of feed efficiency. Feed conversion ratio is a mathematical measure to calculate 
the animal’s ability to use the nutrients given in the diet (Shike, 2011). Since feed 
makes up the primary cost for broiler producers, feed efficiency is very important 
for profit yields. The broiler industry attempts to reduce the amount of feed 
required to grow birds to a constant weight in a given period of time. For this 
study, d15, d33, and d55 were chosen as they were the days that the broilers 
switched diets. At d15, the chickens had completed eating the starter diets and 
were switched to a grower diet. At d33, they switched from grower to withdrawal. 
At d55, all feed was removed as the birds were prepared for processing. For this 
study, the average body weight, feed conversion ratio and adjusted feed 
conversion ratio were determined. Treatment means for average body weight 
and feed conversion ratio are shown in Table 3. Table 4 displays the analysis of 
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Table 3. Average Body Weight & Feed Conversion Ratio for Treatments 1-8, 
Day 15, & 33 



















1 NC 0.688abc  1.24ab  3.525ab 1.71a 
2 PC 0.678abc 1.26a 3.563a  1.67ab 
3 LS + AGP 0.696ab  1.24ab 3.591a 1.67b 
4 LMS + AGP 0.706a 1.21b 3.574a 1.66b 
5 LS + NO AGP 0.695ab  1.22ab  3.514ab  1.67ab 
6 
LMS + NO 
AGP 








0.667bc  1.24ab 3.421b  1.68ab 
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Table 3 shows the average body weight and feed conversion ratios for 
days 15 & 33. On day 15, there was a significant difference for average body 
weight when the researcher compared treatment 4 and treatment 6, 7, & 8 but 
not significant when compared to the remaining treatments. Treatment 4 showed 
the largest body weight and treatment 7 showed the smallest body weight. Feed 
conversion ratio for day 15 also showed treatment 4 was significantly different 
from treatment 2 but was not significant when compared to the remaining 
treatments. Treatment 4 had the lowest feed conversion, while treatment 2 had 
the highest feed conversion.   
 On day 33, average body weight for treatments 2, 3, & 4 were significantly 
different from treatments 7 & 8, but were not significantly different from 
treatments 1, 5, & 6. Treatment 3 had the largest body with the lowest feed 
conversion ratio, following closely behind was treatment 4. Treatment 3 had an 
increase in body weight and feed conversion compared to the other treatments. 
The results also showed treatments 3 & 4 were significantly lower than treatment 
for feed conversion ratio, but not significantly different when compared to the 
remaining treatments.   
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  Table 4. ANOVA of Body Weight, Treatments 1-8, Day 15 & 33 
Source DF Mean Square 
  D15 D33 
Block 11 0.00411553 0.03313741 
Treatment 7 0.00297321 0.04234866 
Error 77 0.00101445 0.01500450 
Total 95 0.14419583 1.81629896 
Pr>F  0.0090 0.0113 
 
  
Table 5. ANOVA of Feed Conversion Ratio for Treatments 1-8, Day 15 & 33 
Source DF Mean Square 
  D15 D33 
Block 11 0.00211847 0.00825786 
Treatment 7 0.00292842 0.00338557 
Error 77 0.00236479 0.00259141 
Total 95 0.22589063 0.31407396 
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Figure 1 compares the average body weight and feed conversion ratio for 
day 15. The bar graph represents the relationship of the average body weight 
and feed conversion ratio. It supports the claim that Table 1 showed statistical 
differences between treatments treatment 4 and treatment 6, 7, & 8 for average 
body weight. Feed conversion ratio for day 15 also showed a significant 
difference between treatment 2 and treatment 4.  
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Figure 2 compares the average body weight and feed conversion ratio for 
day 33. The bar graph represents the relationship of the average body weight 
and feed conversion ratio. It supports the claim from Table 1 showing treatments 
2, 3, & 4 were significantly different from treatments 7 & 8 for average body 
weight. Figure 2 also shows a significant difference between treatment 1, 
compared to treatment 3 & 4 for feed conversion ratio.  
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Table 6 shows the average body weight, feed conversion ratio and 
adjusted feed conversion ratio for treatments 1-8 at day 55. There was no 
significant difference at day 55 for average body weight or feed conversion ratio.  
Although there was no significant differences, treatment 3, produced the largest 
average body weight but the feed conversion ratio was only 0.03 lbs. higher than 
treatment 6 & 8, which had the lowest feed conversion ratio. Treatment 1 & 
treatment 8 showed to have the smallest average body weight. Treatment 1 
reported the highest feed conversion at a 1.94 while treatment 8 produced one of 
the lowest feed conversion ratios at a 1.90. 
 
Table 6. Average Body Weight, Feed Conversion Ratio, and Adjusted Feed 











1 7.605a 1.942a 1.794a 
2 7.623a 1.942a 1.789a 
3 7.700a 1.937a  1.776a 
4 7.652a 1.922a  1.766a 
5 7.666a 1.915a  1.760a 
6 7.653a 1.903a  1.749a 
7 7.653a 1.933a  1.779a 
8 7.607a 1.908a  1.760a 
*Means with the same letters are not significantly different (p<0.05). 
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Feed conversion ratio was adjusted for a 7 lb. bird on a 1450 calorie diet 
with a 7 point weight/point of feed conversion ratio. The following formula was 
used to calculate adjusted feed conversion ratio.  
Step 1: (Actual Avg. Body Weight – 7.00) / 7 = X1 
 (Actual Feed Conversion Ratio – X1) = X2   
Step 2: (X2 * 1450) kcal / 1500 std kcal = Adjusted Feed Conversion ratio for 
Avg. Body Weight 
 
 
Table 7. ANOVA of Average Body Weight, Day 55 
Source DF Type I SS 
Mean 
Square 
F Value Pr>F 
Block 11 0.75387812 0.06853437 1.62 0.1097 
Treatment 7 0.08518229 0.01216890 0.29 0.9569 
Error 77 3.25733021 0.04230299   
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Table 8. ANOVA of Feed Conversion Ratio, Day 55 
Source DF Type I SS 
Mean 
Square 
F Value Pr>F 
Block 11 0.03951146 0.00359195 1.16 0.3320 
Treatment 7 0.02005729 0.00286533 0.92 0.4946 
Error 77 0.23938021 0.00310883   
Total 95 0.29894896    
 
 
Table 9. ANOVA of Adjusted Feed Conversion Ratio without Mortality, Day 
55 
Source DF Type I SS 
Mean 
Square 
F Value Pr>F 
Block 11 0.07783750 0.00707614 1.31 0.2337 
Treatment 7 0.02036250 0.00290893 0.54 0.8018 
Error 77 0.41506250 0.00539042   
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Figure 3 compares the average body weight and feed conversion ratio for 
day 55. The bar graph represents the relationship of the average body weight 
and feed conversion ratio. It supports the claim of Table 1 showed there was no 
significant difference between treatments 1-8.  
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Mortality 
 Mortality was measured on the same days as both average body weight 
and feed intake. A significant difference was not only seen in percent livability, 
but also in mortality percent in treatments 6 & 7 compared to treatment 5 but not 
the remaining treatments. It is also noted that, average mortality body weight 
showed a significant difference in treatment 7 compared to treatment 2; the 
remaining treatments were not significantly different. Treatment 5 had the lowest 
average mortality bodyweight and lowest percent mortality but an average 
mortality body weight of 7.833, which indicates broilers died near the end of the 
study.  
Table 10. Percent Mortality (%), Treatments 1-8, Day 1-55 











1  94.167ab   5.833ab  6.728ab 
2  94.500ab   5.500ab 6.274b 
3  94.167ab   5.833ab  7.552ab 
4  94.167ab   5.833ab  7.128ab 
5 95.333b  4.667b  7.833ab 
6 92.167a  7.833a  7.768ab 
7 91.833a  8.167a 9.688a 
8   93.667ab   8.167ab  7.659ab 
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Table 11. ANOVA of Mortality, Treatments 1-8, Day 1-55 
Source DF Total Mortality  
  Type 1 SS Mean Square F Value Pr>F 
Block 11 52.00000000 4.72727273 2.03 0.0363 
Treatment 7 29.33333333 4.19047619 1.80 0.0991 
Error 77 179.1666667 2.3268398   
Total 95 260.5000000    
 
Table 12. ANOVA of Total Mortality Body Weight, Treatments 1-8, Day 1-55   
Source DF Total Mortality Body Weight 
  Type 1 SS Mean Square F Value Pr>F 
Block 11 228.4544365 20.7685851 1.73 0.0833 
Treatment 7 86.1932490 12.3133213   1.02 0.4221 
Error 77 926.836639 12.036839   
Total 95 1241.484324    
 
Table 13. ANOVA of Total Mortality Percent (%), Treatments 1-8, Day 1-55 
Source DF Total Mortality Percent (%) 
  Type 1 SS Mean Square F Value Pr>F 
Block 11 208.0000000 18.9090909 2.03   0.0363 
Treatment 7 117.3333333 16.7619048 1.80   0.0991 
Error 77 716.666667 9.307359   
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Pyrosequencing   
Lactobacillus is a genus of gram-positive, facultative anaerobic or 
microaerophilic, rod-shaped, non-spore-forming bacteria, normally found in the 
GI-tract (Makarova et al., 2006). Lactobacillus creates lactic acid from the 
utilization of carbohydrates. Enterococcus is a large genus of lactic acid bacteria 
of the phylum Firmicutes. Enterococci are gram-positive cocci that often occur in 
pairs or short chains, and are difficult to distinguish from Streptococci on physical 
characteristics alone and are usually found in the intestinal tract (Gilmore, 2002). 
Brachybacterium is a coryneform bacterium from poultry deep litter (Collins et al., 
1988). Bacillus is a genus of gram-positive, rod-shaped bacteria and a member 
of the phylum Firmicutes. Under stressful environmental conditions, the bacteria 
can produce oval endospores that are not true 'spores', but to which the bacteria 
can reduce themselves and remain in a dormant state for very long periods 
(Turnbull et al., 2002). B. subtilis has proved a valuable model for research. 
Other species of Bacillus are important pathogens, causing anthrax and food 
poisoning. Virgibacillus is a genus of gram-positive, rod-shaped bacteria and a 
member of the phylum Firmicutes. Virgibacillus species can be obligate aerobes, 
or facultative anaerobes and catalase enzyme positive. Under stressful 
environmental conditions, the bacteria can produce oval or ellipsoidal 
endospores in terminal, or sometimes subterminal, swollen sporangia (Kampfer 
et al., 2010). Paenibacillus is a genus of facultative anaerobic, endospore-
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forming bacteria, originally included within the genus Bacillus and then 
reclassified as a separate genus in 1993 (Ash et al., 1993). Bacteria belonging to 
this genus have been detected in a variety of environments, such as: soil, water, 
rhizosphere, vegetable matter, forage and insect larvae, as well as clinical 
samples. 
Escherichia is a genus of gram-negative, nonspore forming, facultatively 
anaerobic, rod-shaped bacteria from the family Enterobacteriaceae (Madigan & 
Martinko, 2005). In those species which are inhabitants of the gastrointestinal 
tracts of warm-blooded animals, Escherichia species provide a portion of the 
microbially derived vitamin K for their host. Streptococcus is a genus of coccus 
(spherical) gram-positive bacteria belonging to the phylum Firmicutes and the 
order Lactobacillales (Ryan & Ray, 2004). Cell division in this genus occurs along 
a single axis in these bacteria; thus they grow in chains or pairs, meaning easily 
bent or twisted, like a chain. Clostridium is a genus of gram-positive, anaerobic 
bacteria, which includes several significant human pathogens, including the 
causative agent of botulism and an important cause of diarrhea, Clostridium 
difficile (Maczulak, 2011). Clostridium endospores have a distinct bowling pin or 
bottle shape, distinguishing them from other bacterial endospores, which are 
usually ovoid in shape. Clostridium species inhabit soils and the intestinal tract of 
animals, including humans (Maczulak, 2011). Staphylococcus is a genus of 
gram-positive bacteria. Under the microscope, they appear round, and form in 
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grape-like clusters. Found worldwide, they are a small component of soil 
microbial flora.  
Pyrosequencing data is shown below in tables 14, 15, & 16. There were 
no significant differences between any treatments 1, 3, 5, & 7 for day 25, 35, or 
55. The study consisted of 4 replications of each treatment. The researcher only 
selected to test the samples for treatment 1, 3, 5 & 7 because treatments without 
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Pyrosequencing Data 














Pr > F 
Lactobacillus 
 
90975.00 98951.25 96167.00 88175.25 0.0905 
Enterococcus 
 
14663.25 9922.75 11459.00 9697.00 0.7593 
Escherichia 
 
370.75 948.50 209.50 32.75 0.5489 
Streptococcus 
 
20949.50 6759.50 33153.75 4601.00 0.1811 
Clostridium 
 
7074.25 4500.50 4436.00 3898.50 0.6983 
Brachybacterium 
 
2175.50 5268.25 3566.25 2708.75 0.5977 
Staphylococcus 
 
2932.00 6003.50 2054.50 3024.75 0.4509 
Bacillus subtilis 
 
839.50 1244.00 687.25 700.75 0.5010 
Virgibacillus 
 
641.75 579.50 739.00 682.75 0.4596 
Paenibacillus 
 
522.25 183.75 111.50 163.25 0.3286 
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Pr > F 
Lactobacillus 
 
22259.75 20565.00 27420.50 36500.75 0.2388 
Enterococcus 
 
47981.25 47985.25 60271.00 37140.25 0.4273 
Escherichia 
 
32292.75 27625.50 32379.25 19538.25 0.2745 
Streptococcus 
 
5262.25 12865.50 8335.25 7661.75 0.2337 
Clostridium 
 
1941.25 4692.00 4963.25 4132.50 0.5169 
Brachybacterium 
 
180.75 229.50 404.00 237.25 0.5114 
Staphylococcus 
 
676.50 542.50 438.50 820.75 0.0876 
Bacillus subtilits 
 
1506.50 1608.75 645.75 751.00 0.8113 
Virgibacillus 
 
124.75 161.50 29.25 66.00 0.6298 
Paenibacillus 
 
189.00 202.50 116.50 183.75 0.3587 
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Pr > F 
Lactobacillus 
 
126203.25 111335.75 141655.25 122360.50 0.8487 
Enterococcus 
 
19006.25 18872.50 5846.00 21146.25 0.8864 
Escherichia 
 
132.75 7792.00 1948.75 4678.25 0.6869 
Streptococcus 
 
3101.75 2599.75 1156.75 2535.75 0.7961 
Clostridium 
 
267.50 2266.75 996.00 3086.75 0.4651 
Brachybacterium 
 
3643.00 3078.25 1653.00 3173.75 0.2651 
Staphylococcus 
 
2040.25 485.25 362.00 617.25 0.4592 
Bacillus subtilis 
 
1170.75 1162.00 225.00 361.25 0.0805 
Virgibacillus 
 
1448.00 422.50 117.00 93.00 0.4109 
Paenibacillus 
 
195.75 126.75 41.50 83.25 0.1676 
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Carcass Yield 
Table 17. Yield Data Results by Treatment, Day 55 
































7.78a 7.78a 7.83a 7.77a 7.79a 7.67a 7.80a 7.72a 








2.23a 2.17ab 2.23a 2.23a 2.22a 2.17ab 2.20a 2.07b 
Breast 1.44a 1.44a 1.50a 1.45a 1.46a 1.43a 1.48a 1.44a 
Tenders 0.33a 0.32a 0.34a 0.31a 0.35a 0.33a 0.32a 0.31a 
Wings 0.59a 0.57ab 0.58ab 0.59a 0.58ab 0.58ab 0.59a 0.56b 
Drums 0.75a 0.71a 0.73a 0.73a 0.73a 0.72a 0.72a 0.72a 
Thighs 0.94ab 0.93ab 0.97ab 0.98ab 0.99a 0.94ab 0.96ab 0.92b 
Skin 0.21ab 0.21ab 0.22a 0.22a 0.22a 0.19b 0.22a 0.20ab 
Fat Pad 0.12a 0.11ab 0.11ab 0.10ab 0.10ab 0.12ab 0.10b 0.12a 
Frame 0.78a 0.78a 0.76a 0.79a 0.78a 0.79a 0.78a 0.78a 
Back 0.54a 0.52ab 0.51ab 0.52ab 0.53ab 0.50b 0.51ab 0.50ab 
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The yield study was conducted by randomly selecting 4 birds, 2 females 
and 2 males identified by sexual characteristics, from each treatment pen within 
each pen. This allowed for a representative sample to be used for the entire 
flock.  
Table 18. ANOVA of Hind Half for Treatment 1-8, Day 55 
Source DF Hind Half 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.55562676 0.05051152 0.68 0.7544 
Treatment 7 1.05810566 0.15115795 2.05 0.0488 
Error 364 26.90084661 0.07390342   
Total 383 52.03945410    
 
 A significant difference was recorded in the hind half carcass yield ANOVA 
Table 18 (p=0.0488). Treatment 8 produced the lowest average hind half carcass 
weight with 2.07 lbs. when compared to the heaviest weights at 2.24 lbs. shown 
by treatments 1, 3, 4, 5, & 7.  
  
Table 19. ANOVA of Skin for Treatment 1-8, Day 55 
Source DF Skin 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.00904192 0.00082199 0.41 0.9517 
Treatment 7 0.03328808 0.00475544 2.37 0.0223 
Error 362 0.72680692 0.00200775   
Total 381 0.79192230    
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 The ANOVA Table 19 showed a significant difference (p=0.0223) in skin 
weights. Treatment 6 produced the lightest skin weights at 0.19 lbs. while 
treatments 3, 4, 5, & 7 weighed in at 0.22 lbs. 
Table 20. ANOVA of Fat Pad for Treatment 1-8, Day 55 
Source DF Fat Pad 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.02720909 0.00247355 1.04 0.4139 
Treatment 7 0.03153354 0.00450479 1.89 0.0707 
Error 358 0.85495607 0.00238815   
Total 377 0.91479762    
 
 The results from ANOVA Table 20, shows no significant difference among 
treatments. Treatment 1 & treatment 8 were heavier with fat pad yields of 0.127 
lbs. and 0.126 lbs. Treatment 7 was also noted to be lighter at 0.100 lbs.  
Table 21. ANOVA of Back for Treatment 1-8, Day 55 
Source DF Back 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.03897412 0.00354310 0.67 0.7711 
Treatment 7 0.05283879 0.00754840 1.42 0.1967 
Error 361 1.92167152 0.00532319   
Total 380 3.37478228    
 
 No significant differences were detected for back yield as seen in ANOVA 
Table 21. Treatment 1 was the heaviest with a yield weight of 0.542 lbs. 
Treatment 6 was the lightest yield weight with 0.502 lbs.  
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There were no significant differences shown in the ANOVA tables 22-30 
live weights, without giblets, front-half, breast, tenders, wings, drums, thighs, and 
frame.  
Table 22. ANOVA of Live Weight for Treatment 1-8, Day 55 
Source DF Live Weight 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 6.787499 0.617045 1.56 0.1089 
Treatment 7 0.901969  0.1288528 0.33 0.9422 
Error 364 144.0570760 0.395761   
Total 383 321.8270490    
 
Table 23. ANOVA of Without Giblets for Treatment 1-8, Day 55 
Source DF WOG 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 2.95463250  0.26860295 1.00 0.4436 
Treatment 7 0.52830919  0.07547274 0.28 0.9610 
Error 363 97.2697298 0.2679607   
Total 382 195.7984387    
 
Table 24. ANOVA of Front Half for Treatment 1-8, Day 55 
Source DF Front Half 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 2.20517572 0.2004705 1.46 0.1429 
Treatment 7 0.3795218 0.0542174 0.40 0.9046 
Error 364 49.83723516 0.1369154   
Total 383 74.19370150    
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Table 25. ANOVA of Breast for Treatment 1-8, Day 55 
Source DF Breast 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.90027681 0.08184335 2.26 0.0114 
Treatment 7 0.17936120 0.02562303 0.71 0.6658 
Error 362 13.11108152 0.03621846   
Total 381 18.03109247    
 
 
Table 26. ANOVA of Tenders for Treatment 1-8, Day 55 
Source DF Tenders 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.09770325 0.00888211 0.82 0.6190 
Treatment 7 0.06469097 0.00924157 0.85 0.5430 
Error 362 3.91589478 0.01081739   
Total 381 4.21327522    
 
 
Table 27. ANOVA of Wings for Treatment 1-8, Day 55 
Source DF Wings 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.03487429 0.00317039 0.72 0.7179 
Treatment 7 0.04275196 0.00610742 1.39 0.2082 
Error 362 1.59060247 0.00439393   
Total 381 2.55895611    
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Table 28. ANOVA of Drums for Treatment 1-8, Day 55 
Source DF Drums 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.11296376 0.01026943 1.20 0.2884 
Treatment 7 0.04088500 0.00584071 0.68 0.6892 
Error 362 3.11005130 0.00859130   
Total 381 6.30928357    
 
Table 29. ANOVA of Thighs for Treatment 1-8, Day 55 
Source DF Thighs 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.12673154 0.01152105    0.68 0.7563 
Treatment 7 0.19412819 0.02773260   1.64 0.1228 
Error 362 6.11982573 0.01690560   
Total 381 9.87675216    
 
Table 30. ANOVA of Frame for Treatment 1-8, Day 55 
Source DF Frame 
  Type 1 SS Mean Square F  Value Pr>F 
Block 11 0.29767364 0.02706124 3.56 <.0001 
Treatment 7 0.02245445 0.00320778 0.42 0.8882 
Error 362 2.74887481 0.00759358   
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CHAPTER V 
Summary and Conclusion 
 From this study, it was determined probiotics Bacillus licheniformus, 
Bacillus megaterium, and Bacillus subtilis could all potentially be substituted for 
antibiotic growth promotors with no negative impact on average body weight, and 
feed conversion ratio.  When compared to the negative control, treatment 1, 
treatment 3 produced the highest average yield weights. The results shown in 
Table 3 indicate the information near the beginning of the study, treatments 3 & 4 
have a slightly heavier bird than treatments 5 & 6 at day 15, and again on day 33. 
This trend could be due to the fact that the probiotic might not have had enough 
time to establish itself within the microbiota of the intestinal tract. The bioshuttle 
programs in treatments 7 & 8 were lighter on average body weights on days 15 
and 33. This is expected because of the vaccine given at the beginning of the 
study causes a mild infection in order to stimulate immunity. While treatments 7 & 
8 were behind the other treatments at d15, & d33, they exhibited compensatory 
gain to be similar to the rest by d55. Looking at the data in Table 3, no significant 
differences were shown on day 55 for average body weight or average feed 
conversion ratio. Yet, treatment 5 did not include an antibiotic growth promotor 
and proved to be within 0.04 lbs. of the average body weight and a 0.02 lbs. 
lower feed conversion than treatment 3. Treatment 6 had the same average body 
weight as treatment 4 at 7.65 lbs. but had a lower feed conversion with a 
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difference of 0.02 lbs. at 1.90 lbs. Even though main cuts from the yield weights 
did not show a significant difference, it is noted that the treatments with probiotics 
included were similar to the control groups. Studies by Apata (2008) indicated 
that Lactobacillus in addition to broiler chick diets significantly improved growth 
performance, increased nutrient digestibility and stimulated humoral immune 
response. Although we did not see any statistical difference in treatments with 
probiotics, the weights proved to be equal to or heavier compared to the control 
groups. Further studies should be conducted to determine more significant 
differences between probiotics and antibiotic growth promotors. The intestine 
samples that were analyzed throughout this study did not show a significant 
difference between any of the treatments. The samples taken from the intestines 
proved to be clean and did not show any evidence of challenge within the bird. 
Again, further studies should be conducted to see the possibility for probiotics to 
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